Hemostatic, antibacterial and healing-promoting material and preparation method thereof

Through the combination of small molecule keratin and polysaccharide, layered porous sponge dressings are prepared using directional freeze-drying technology, which solves the problems of excessive blood sucking and delayed infection of existing hemostasis dressings, and achieves rapid blood sucking, powerful antibacterial and healing effects. , ensure the biosafety and simple synthesis of materials.

CN119074991APending Publication Date: 2024-12-06INST OF BIOLOGICAL & MEDICAL ENG GUANGDONG ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411281679.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-13
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing hemostatic dressings have problems in the excessive blood sucking that lead to unnecessary blood loss and bacterial infection delay wound healing, and the addition of organic solvents or crosslinking agents during preparation limits their application in medicine.

Method used

Using small molecule keratin and polysaccharide as substrates, layered porous sponge dressings with hemostatic, antibacterial and pro-healing properties are prepared through directional freeze-drying technology. Keratin peptides are used to form dense bubble structures and pore channels, combining natural polysaccharides and crosslinking agents , construct materials with high efficiency liquid and gas transmission rates.

Benefits of technology

It achieves rapid absorption of blood, significantly improves antibacterial properties and promotes healing, reduces medical costs and patient risks, and the materials are biosafe and simple and gentle.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005041823810000041
    Figure BDA0005041823810000041
  • Figure HDA0005041823820000011
    Figure HDA0005041823820000011
  • Figure HDA0005041823820000012
    Figure HDA0005041823820000012
Patent Text Reader

Abstract

The invention discloses a hemostatic, antibacterial and healing-promoting material and a preparation method thereof. The material comprises polysaccharide, keratin and a cross-linking agent, wherein the molecular weight of the keratin is less than 1KD. The directional layered porous sponge material with the functions of stopping bleeding, resisting bacteria and promoting healing is constructed by taking small molecular keratin peptide and polysaccharide as matrixes and adopting a directional freeze-drying technology; due to the introduction of keratin peptide, the performance of absorbing a large amount of blood can be greatly improved, and the antibacterial property and the healing promotion property of the material are synergistically improved; the directional freezing technology endows the sponge with axially ordered and regular pore channels, so that the sponge has a more efficient liquid transmission rate; all the components are natural, the synthesis method is simple and mild, and the biological safety and the biological activity of the material are ensured only by carrying out a cross-linking reaction at room temperature. The material can also be used for loading skin transforming growth factors, antibacterial drugs, antibacterial biological materials, antibacterial metal nanoparticles and the like so as to promote healing of acute or chronic wounds.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biomedicine, and specifically relates to a hemostatic, antibacterial and healing-promoting material and a preparation method thereof. Background Art

[0002] Massive bleeding and wound infection are the key causes of death in traumatic events, combat injuries and daily life. Common hemostatic dressings cause unnecessary blood loss due to excessive blood absorption. At the same time, bacterial infection greatly delays the process of wound healing and may cause further damage to the wounded. Therefore, the development of highly effective antibacterial, rapid hemostasis and healing-promoting biological dressings has important application significance in medicine. Ideal wound dressings should have the following characteristics: they can provide a moist environment for the skin and have ventilation, absorb wound exudate and allow gas exchange; they can promote cell migration, angiogenesis and connective tissue growth; they have obvious antibacterial effects and good biocompatibility.

[0003] Although many dressings have been used for hemostasis and wound healing, the preparation of ideal dressings with the above properties still faces some challenges. For example, the addition of organic solvents or cross-linking agents during the preparation process will limit its application in medicine, and the complex synthesis technology route will also limit its application in biomedicine. Compared with synthetic materials, naturally derived biomaterials have excellent biocompatibility, promotion of cell adhesion, proliferation and migration, and are widely used in the medical field, including promoting healing, preventing infection, and restoring skin structure and function. Therefore, one of the current focuses of wound dressing research is to prepare biomedical materials using low-cost, biosafe natural biological raw materials and their derivatives. Summary of the invention

[0004] The first aspect of the present invention aims to provide a composition.

[0005] The second aspect of the present invention aims to provide the application of the above composition.

[0006] The third aspect of the present invention aims to provide an antibacterial and / or hemostatic and / or healing promoting material.

[0007] The fourth aspect of the present invention aims to provide a method for preparing the above-mentioned material.

[0008] The technical solution adopted by the present invention is:

[0009] The first aspect of the present invention provides a composition, which comprises polysaccharide, keratin and a cross-linking agent; the molecular weight of the keratin is less than 1KD.

[0010] In some embodiments of the present invention, the mass ratio of the polysaccharide, keratin and cross-linking agent is 5:2 to 5:0.2 to 1.

[0011] In some embodiments of the present invention, the mass ratio of the polysaccharide, keratin, and cross-linking agent is 5:3.75:0.9375.

[0012] In some embodiments of the present invention, the polysaccharide includes at least one of chitosan, hyaluronic acid, cellulose, and sodium alginate.

[0013] In some embodiments of the present invention, the cross-linking agent includes at least one of genipin, tannic acid, and glutaraldehyde.

[0014] In some embodiments of the present invention, the keratin is derived from materials containing keratin, such as skin, hair, nails, horns, hooves, scales, and beaks.

[0015] In some embodiments of the present invention, the keratin is derived from at least one of duck feathers, chicken feathers, goose feathers, and duck feathers.

[0016] The second aspect of the present invention provides use of the composition described in the first aspect of the present invention in the preparation of antibacterial and / or hemostatic and / or healing promoting materials.

[0017] The third aspect of the present invention provides an antibacterial and / or hemostatic and / or healing promoting material, wherein the material comprises the composition described in the first aspect of the present invention.

[0018] The fourth aspect of the present invention provides a method for preparing the material according to the third aspect of the present invention, comprising the following steps:

[0019] 1) mixing keratin and polysaccharide aqueous solutions uniformly, adding a biocrosslinking agent and continuing to stir to obtain a mixed solution;

[0020] 2) placing the mixed solution in step 1) in a mold for directional freezing, and preparing antibacterial and / or hemostatic and / or healing promoting materials by freeze drying technology.

[0021] In some embodiments of the present invention, after the keratin and polysaccharide aqueous solutions are mixed in step 1), the solution quickly forms dense bubbles and a pore structure on the sheet, which means the mixing is uniform.

[0022] In some embodiments of the present invention, the polysaccharide aqueous solution is prepared by dissolving the polysaccharide in an acetic acid aqueous solution to obtain the polysaccharide aqueous solution.

[0023] In some embodiments of the present invention, the volume concentration of the acetic acid aqueous solution is 0.5-5% v / v.

[0024] In some embodiments of the present invention, the mass volume ratio of the polysaccharide to the acetic acid aqueous solution is 1 to 4 g / 100 mL.

[0025] In some embodiments of the present invention, the stirring time in step 1) is 4 to 12 hours.

[0026] The beneficial effects of the present invention are:

[0027] The present invention uses small molecule keratin peptides and polysaccharides as a matrix and adopts directional freeze-drying technology to construct a directional layered porous sponge dressing with hemostasis, antibacterial and healing-promoting properties; the introduction of keratin peptides makes each layer full of holes, which can greatly improve the rapid absorption of blood on wounds with heavy bleeding, and also synergistically improve the antibacterial and healing-promoting properties of polysaccharide sponge dressings; directional freezing technology gives the sponge axially ordered and regular pore channels, so that it has a more efficient liquid transmission rate; and all sponge components are derived from nature, each component is both a structural unit and a functional unit, the synthesis method is simple and mild, and only a cross-linking reaction needs to be carried out at room temperature to ensure the biosafety and bioactivity of the material. The sponge dressing can also be used to load skin transforming growth factor, antibacterial drugs, antibacterial biomaterials, and antibacterial metal nanoparticles to promote the healing of acute or chronic wounds.

[0028] Compared with pure polysaccharide oriented sponges, the introduction of keratin peptides not only gives the sponge axially ordered and regular pore channels, but also the sheets are covered with uniform pore structures, which makes the sponge have a more efficient liquid and gas transmission rate, which helps to quickly absorb blood in wounds, allowing better oxygen penetration to accelerate healing, reduce pain and infection, thereby helping to reduce overall medical costs and mitigate patient risks. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 This is the GPC room temperature gel chromatogram of the keratin peptide (<1KD) used in Example 1.

[0030] Figure 2 This is a comparison chart of foaming in the experiments of the small molecular weight keratin peptide used in Example 1 and the large molecular weight protein (20KD) used in Comparative Example 2.

[0031] Figure 3 a) is a SEM image of the oriented CS sponge and the oriented layered porous CSKP sponge dressing of Example 1; Figure 3 b)- Figure 3 c) Images and quantitative data of the antibacterial performance test of the sponge material against Staphylococcus aureus and Escherichia coli, respectively.

[0032] Figure 4 The hemostatic properties of the sponge materials prepared in Example 1 and Comparative Example 1.

[0033] Figure 5 These are photos of the healing morphology of rat infectious wounds using sponge materials prepared in Example 1 and Comparative Example 1.

[0034] Figure 6 This is a bar graph for quantitative analysis of the wound healing rate of the sponge material S. aureus of the control, Example 1 and Comparative Example 1 (n=6).

[0035] Figure 7 This is a bar graph for quantitative analysis of wound healing rates of sponge material E.coil of control, Example 1 and Comparative Example 1 (n=6). DETAILED DESCRIPTION

[0036] The following will be combined with the embodiments to clearly and completely describe the concept of the present invention and the technical effects produced, so as to fully understand the purpose, characteristics and effects of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, other embodiments obtained by those skilled in the art without creative work are all within the scope of protection of the present invention.

[0037] Experimental Materials:

[0038] Small molecular weight (<1KD) keratin peptide (KP) was purchased from Shaanxi Zhongyi Kangjian Biotechnology Co., Ltd. (obtained by enzymatic degradation). The GPC room temperature gel chromatogram and molecular weight data of small molecular weight keratin peptide are shown in Figure 1 and Table 1.

[0039] Table 1

[0040]

[0041] High molecular weight (20KD) keratin was purchased from Shaanxi Panier Biotechnology Co., Ltd.

[0042] Example 1

[0043] 1) Weigh 2 g of chitosan (CS) and dissolve it in 100 mL of 2% (v / v) acetic acid aqueous solution, filter and set aside to obtain a CS aqueous solution;

[0044] 2) Mix 300 mg of low molecular weight (<1KD) KP with 20 mL of CS aqueous solution in step 1) and stir. The solution quickly forms dense bubbles ( Figure 2 ), leading to the formation of a pore structure on the sheet.

[0045] 3) Add 75 mg of tannic acid to the mixed solution in step 2) and continue stirring for 8 h.

[0046] 4) The mixed liquid in step 3) is placed in a mold for directional freezing, with liquid nitrogen as a cold source. The mixed liquid is placed in a mold for directional freezing (-80°C), with liquid nitrogen as a cold source, providing a bottom-up temperature gradient to directionally freeze the suspension. The ice crystals grow along the freezing direction, and the mixed liquid is squeezed to the interface between the ice crystals to achieve solid-liquid separation. Finally, through freeze drying (-40°C), the ice crystals are transformed into gas by sublimation, leaving a CSKP sponge with an axially highly oriented layered porous structure.

[0047] Comparative Example 1

[0048] The only difference from Example 1 is that low molecular weight KP is not added, and the other steps are the same.

[0049] 1) Weigh 2 g of chitosan (CS) and dissolve it in 100 mL of 2% (v / v) acetic acid aqueous solution, filter and set aside to obtain a CS aqueous solution.

[0050] 2) Add 75 mg of tannic acid to 20 mL of the CS aqueous solution in step 1) and stir for 8 h.

[0051] 3) The mixed solution in step 2 is placed in a mold for directional freezing, with liquid nitrogen as a cold source. The mixed solution is placed in a mold for directional freezing (-80°C), with liquid nitrogen as a cold source, providing a bottom-up temperature gradient to directionally freeze the suspension. The ice crystals grow along the freezing direction, and the mixed solution is squeezed to the interface between the ice crystals to achieve solid-liquid separation. Finally, through freeze drying (-40°C), the ice crystals are transformed into gas by sublimation, leaving a highly axially oriented directional sponge dressing (CS sponge).

[0052] Comparative Example 2

[0053] The other steps are the same as those in Example 1, except that the keratin used is a high molecular weight keratin (20KD), which results in the solution in step 2) not being able to form dense bubbles, i.e., not being able to obtain a layered porous structure ( Figure 2 ).

[0054] Effect Example 1

[0055] 1. The CSKP sponge in Example 1 and the CS sponge in Comparative Example 1 absorbed whole blood and recorded the absorption time; the results are shown in Figure 4 The results show that compared with comparative example 1, the addition of KP results in a porous structure on each layer, which makes the sponge have a more efficient liquid transmission rate, which helps to quickly absorb blood in the wound.

[0056] 2. The antibacterial activity of the sponge was tested using S. aureus and E. coil as the test strains. The bacteria were reactivated twice for the experiment. The bacterial stock solution was added to the sterilized broth and cultured for 12 hours at 37°C and 150 rpm / min. Before the bacterial culture, the sponge samples were exposed to ultraviolet light for 24 hours. The initial concentration of the bacterial suspension was 10 7 CFU / mL, 10 mg of sponge was mixed with 10 mL of bacterial solution and placed in a test tube, which was placed on a constant temperature incubator shaker and cultured at 37°C at 120 r / min for 1 h. Then, the diluted suspension was inoculated on a sterilized LB agar plate and cultured in a 37°C incubator for 24 h. The number of bacteria was counted and the inhibition rate was calculated.

[0057] Wherein, inhibition rate (%) = (number of bacteria in the blank group - number of bacteria in the sample group) / number of bacteria in the sample group × 100%;

[0058] The results are as follows Figure 3 As shown in a), the results show that compared with pure chitosan sponge materials, the introduction of keratin peptides allows the sponge layer to form a porous structure, which can greatly increase the porosity of the sponge dressing and has potential advantages in the absorption rate of liquid. Figure 3 b)- Figure 3 As shown in c), compared with Comparative Example 1, the addition of small molecular weight KP makes the antibacterial sponge have more efficient antibacterial activity.

[0059] 3. Anesthetize the mice with 10% ether, remove the hair, and disinfect with 75% alcohol. Use a hole puncher to make 6 groups of circular wounds with a diameter of about 8 mm on the back of the mice. Use a pipette to drip 50 μL of 1.0×10 7 CFU / mL of Staphylococcus aureus or Escherichia coli liquid was infiltrated for 0.5-1h to construct two infectious wound models. The wound surface without any dressing was used as the blank control group (M group), and each group of directional porous sponge dressings was fixed on the wound surface as the experimental group, and the dressing was replaced once every 3 days. The wound area was recorded on the 0th, 3rd, 6th, 10th and 13th days.

[0060] Measuring wound area: During the wound healing process, the area of ​​the wound needs to be measured regularly. Use a digital camera to take pictures of the wound, and then use image analysis software (such as ImageJ) to measure the wound area. Secondly, record the initial and follow-up wound areas. The initial area of ​​the wound is measured and recorded at the first time after the wound is infected (day 3). The follow-up area is the area of ​​the wound measured at a specific time point during the treatment process. The follow-up time points are 0, 3, 6, 10 and 13 days. The wound healing rate can be calculated by the following formula:

[0061] Wound healing rate (%) = (initial wound area - follow-up wound area) / (initial wound area) × 100%; Results Figure 5-7 As shown, the results show that compared with comparative example 1, the CSKP layered porous sponge has superior antibacterial properties, can shorten the inflammatory phase of wound tissue, enable the wound surface to enter the cell proliferation phase faster, achieve antibacterial debridement and accelerate wound healing.

[0062] The above specific implementations have been described in detail for the present invention, but the present invention is not limited to the above embodiments. Various changes can be made within the knowledge of ordinary technicians in the relevant technical field without departing from the purpose of the present invention. In addition, the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

Claims

1. A composition comprising polysaccharide, keratin and a cross-linking agent; the keratin has a molecular weight of less than 1KD.

2. The composition according to claim 1, characterized in that The mass ratio of the polysaccharide, keratin and cross-linking agent is 5:2 to 5:0.2 to 1.

3. The composition according to claim 1, characterized in that The polysaccharide includes at least one of chitosan, hyaluronic acid, cellulose and sodium alginate.

4. The composition according to claim 1, characterized in that The cross-linking agent includes at least one of genipin, tannic acid and glutaraldehyde.

5. Use of the composition according to any one of claims 1 to 4 in the preparation of antibacterial and / or hemostatic and / or healing promoting materials.

6. An antibacterial and / or hemostatic and / or healing promoting material, comprising the composition according to any one of claims 1 to 4.

7. The method for preparing the antibacterial and / or hemostatic and / or healing promoting material according to claim 6, comprising the following steps: 1) mixing keratin and polysaccharide aqueous solutions uniformly, adding a biocrosslinking agent and continuing to stir to obtain a mixed solution; 2) placing the mixed solution in step 1) in a mold for directional freezing, and preparing antibacterial and / or hemostatic and / or healing promoting materials by freeze drying technology.

8. The method according to claim 7, characterized in that The polysaccharide aqueous solution is prepared by dissolving the polysaccharide in an acetic acid aqueous solution to obtain the polysaccharide aqueous solution; preferably, the volume concentration of the acetic acid aqueous solution is 0.5-5% v / v.

9. The method according to claim 8, characterized in that The mass volume ratio of the polysaccharide to the acetic acid aqueous solution is 1-4 g / 100 mL.

10. The method according to claim 7, characterized in that The stirring time in step 1) is 4 to 12 hours.